| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3940111 | Fertility and Sterility | 2011 | 4 Pages |
Abstract
Abdominal mesotherapy injection of recombinant human FSH (rhFSH) was well tolerated with increased net absorption (AUC0-â 4,655.3 IU·h/L and t1/2 247.6 h) up to 360 hours compared with those of 120 hours (AUC0-â 1,915.7 IU·h/L and t1/2 101.8 h). The extended absorption of rhFSH suggests that abdominal mesotherapy injection mode be considered for future administration of rhFSH in controlled ovarian hyperstimulation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Chao-Chin M.D., Ph.D., Hsin-Chih Ph.D., Chao-Tien M.D., Ph.D., Qing M.D.,